Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: The SEER experience from 2004 to 2011

Journal of Gynecologic Oncology

Volumn 27, Issue 5, 2016, Pages

  Patel, Sagar C ^a   Frandsen, Jonathan ^b   Bhatia, Sudershan ^a,c   Gaffney, David ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Ovary; Radiation; Survival; Uncommon Histology

Indexed keywords

ADJUVANT RADIOTHERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CLEAR CELL CARCINOMA; COLLOID CARCINOMA; COMPARATIVE STUDY; DISEASE COURSE; ENDOMETRIOID CARCINOMA; FEMALE; HEALTH PROGRAM; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; TREATMENT DURATION; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CANCER REGISTRY; CARCINOMA, ENDOMETRIOID; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PATHOLOGY; TIME FACTOR;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; TIME FACTORS;

EID: 84978428085     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2016.27.e45     Document Type: Article

References (13)

1. Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet 2014; 384: 1376-88.
2. Hoskins PJ, Le N, Gilks B, Tinker A, Santos J, Wong F, et al. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol 2012; 30: 1656-62.
3. Rai B, Bansal A, Patel FD, Sharma SC. Radiotherapy for ovarian cancers-redefining the role. Asian Pac J Cancer Prev 2014; 15: 4759-63.
4. Dembo AJ, Bush RS, Beale FA, Bean HA, Pringle JF, Sturgeon J, et al. Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol 1979; 134: 793-800.
5. Sorbe B, Swedish-Norgewian Ovarian Cancer Study Group. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 2003; 13: 278-86.
6. Sirichaisutdhikorn D, Suprasert P, Khunamornpong S. Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin. Asian Pac J Cancer Prev 2009; 10: 1041-5.
7. Swenerton KD, Santos JL, Gilks CB, Köbel M, Hoskins PJ, Wong F, et al. Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers. Ann Oncol 2011; 22: 341-7.
8. Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, et al. Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, Vancouver BC. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 2010; 29: 203-11.
9. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995; 76: 2343-50.
10. Chino JP, Jones E, Berchuck A, Secord AA, Havrilesky LJ. The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer. Int J Radiat Oncol Biol Phys 2012; 82: 1872-9.
11. Rochet N, Sterzing F, Jensen AD, Dinkel J, Herfarth KK, Schubert K, et al. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study. Int J Radiat Oncol Biol Phys 2010; 76: 1382-9.
12. Chang JS, Koom WS, Kim SW, Kim S, Kim YB, Kim YT, et al. Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy. J Gynecol Oncol 2013; 24: 146-53.
13. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol 2013; 130: 300-5.